Catherine Sazdanoff is Director of MERIDIAN BIOSCIENCE INC. Currently has a direct ownership of 0 shares of VIVO, which is worth approximately $0. The most recent transaction as insider was on Jan 31, 2023, when has been sold 16,424 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Catherine Sazdanoff Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2023
SELL
Sale (or disposition) back to the issuer
-
16,424 Reduced 100.0%
0 Common Stock
Jan 26 2022
BUY
Grant, award, or other acquisition
-
3,012 Added 15.5%
16,424 Common Stock
Jan 27 2021
BUY
Grant, award, or other acquisition
-
1,545 Added 10.33%
13,412 Common Stock

Also insider at

INM
InMed Pharmaceuticals Inc. Healthcare
CS

Catherine Sazdanoff

Director
Cincinnati, OH

Track Institutional and Insider Activities on VIVO

Follow MERIDIAN BIOSCIENCE INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIVO shares.

Notify only if

Insider Trading

Get notified when an Meridian Bioscience Inc insider buys or sells VIVO shares.

Notify only if

News

Receive news related to MERIDIAN BIOSCIENCE INC

Track Activities on VIVO